These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7332789)

  • 1. [Contribution of drill-biopsies to pre-treatment investigation of breast adenocarcinomas (author's transl)].
    Mauriac L; Wafflart J; Durand M; Parsi B; de Mascarel I; Trojani M; Meugé-Moraw C
    Bull Cancer; 1981; 68(5):417-21. PubMed ID: 7332789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
    Bolla M; Chedin M; Chambaz E; Gabelle P
    Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
    Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anatomopathology of breast cancer and hormone receptors].
    Contesso G; Delarue JC; Mouriesse H; May-Levin F; Garnier H
    Pathol Biol (Paris); 1983 Nov; 31(9):747-54. PubMed ID: 6361672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drill biopsy and puncture biopsy for the determination of hormone receptors].
    Magdelenat H
    Pathol Biol (Paris); 1983 Nov; 31(9):755-60. PubMed ID: 6361673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
    Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
    Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma.
    Jain V; Landry M; Levine EA
    Am Surg; 1996 Feb; 62(2):162-5. PubMed ID: 8554195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
    Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
    Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
    J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy.
    Cahill RA; Walsh D; Landers RJ; Watson RG
    Ann Surg Oncol; 2006 Jan; 13(1):45-51. PubMed ID: 16378157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
    Cherubini M; Baxa P; Guarino G
    Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.